Human Embryonic Stem Cells: Derivation, Culture, and Differentiation: a Review
Overview
Authors
Affiliations
The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate specialized cells to replace damaged tissue in patients suffering from various degenerative diseases. However, the signaling mechanisms involved in lineage restriction of ESC to adopt various cellular phenotypes are still under investigation. Furthermore, for progression of hESC-based therapies towards clinical applications, appropriate culture conditions must be developed to generate genetically stable homogenous populations of cells, to hinder possible adverse effects following transplantation. Other critical challenges that must be addressed for successful cell implantation include problems related to survival and functional efficacy of the grafted cells. This review initially describes the derivation of hESC and focuses on recent advances in generation, characterization, and maintenance of these cells. We also give an overview of original and emerging differentiation strategies used to convert hESC to different cell types. Finally, we will discuss transplantation studies of hESC-derived cells with respect to safety and functional recovery.
Research Guideline Recommendations for Research on Stem Cells, Human Embryos, and Gene Editing.
Var S, Strell P, Shetty A, Roman A, Clark I, Crane A Cell Transplant. 2025; 34:9636897241312793.
PMID: 40007211 PMC: 11863228. DOI: 10.1177/09636897241312793.
Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review.
Shah S, Mansour H, Lucke-Wold B Cells. 2025; 14(1.
PMID: 39791743 PMC: 11719515. DOI: 10.3390/cells14010042.
Potential of Stem-Cell-Induced Peripheral Nerve Regeneration: From Animal Models to Clinical Trials.
Wynne T, Fritz V, Simmons Z, Zahed M, Seth A, Abbasi T Life (Basel). 2025; 14(12.
PMID: 39768245 PMC: 11679741. DOI: 10.3390/life14121536.
Stem cells and bio scaffolds for the treatment of cardiovascular diseases: new insights.
Razavi Z, Farokhi S, Mahmoudvand G, Karimi-Rouzbahani A, Farasati-Far B, Tahmasebi-Ghorabi S Front Cell Dev Biol. 2024; 12:1472103.
PMID: 39726717 PMC: 11669526. DOI: 10.3389/fcell.2024.1472103.
Advanced therapy to cure diabetes: mission impossible is now possible?.
Rohban R, Martins C, Esni F Front Cell Dev Biol. 2024; 12:1484859.
PMID: 39629270 PMC: 11611888. DOI: 10.3389/fcell.2024.1484859.